156 related articles for article (PubMed ID: 1670689)
1. Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group.
Mathew CG; Easton DF; Nakamura Y; Ponder BA
Lancet; 1991 Jan; 337(8732):7-11. PubMed ID: 1670689
[TBL] [Abstract][Full Text] [Related]
2. Preclinical detection of MEN 2A gene carrier using linked DNA markers.
Tanaka N; Yamamoto M; Miki T; Okazaki M; Sakita I; Shimotake T; Kobayashi T; Miyauchi A; Mori T; Takai S
Jinrui Idengaku Zasshi; 1991 Jun; 36(2):165-70. PubMed ID: 1681126
[TBL] [Abstract][Full Text] [Related]
3. Application of MEN 203 as a polymorphic DNA probe in screening multiple endocrine neoplasia 2a.
Kojima K; Totsuka Y
Endocrinol Jpn; 1991 Dec; 38(6):583-7. PubMed ID: 1688047
[TBL] [Abstract][Full Text] [Related]
4. Linked markers flanking the gene for multiple endocrine neoplasia type 2A.
Nakamura Y; Mathew CG; Sobol H; Easton DF; Telenius H; Bragg T; Chin K; Clark J; Jones C; Lenoir GM
Genomics; 1989 Aug; 5(2):199-203. PubMed ID: 2571570
[TBL] [Abstract][Full Text] [Related]
5. Application of linked DNA markers to screening families with multiple endocrine neoplasia type 2A.
Telenius H; Mathew CG; Nakamura Y; Easton DF; Clark J; Neumann HP; Ziegler WH; Schinzel A; Ponder BA
Eur J Surg Oncol; 1990 Apr; 16(2):134-40. PubMed ID: 1969807
[TBL] [Abstract][Full Text] [Related]
6. Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.
Lamothe EM; Narod SA; Miller S; Goodfellow PJ; Cole DE; Gilchrist D; Pausova Z; Goltzman D; Hendy GN
Henry Ford Hosp Med J; 1992; 40(3-4):224-6. PubMed ID: 1362410
[TBL] [Abstract][Full Text] [Related]
7. Presymptomatic testing using DNA markers for individuals at risk for familial multiple endocrine neoplasia 2A.
Lichter JB; Wu JS; Genel M; Flynn SD; Pakstis AJ; Kidd JR; Kidd KK
J Clin Endocrinol Metab; 1992 Feb; 74(2):368-73. PubMed ID: 1346145
[TBL] [Abstract][Full Text] [Related]
8. Improved predictive test for MEN2, using flanking dinucleotide repeats and RFLPs.
Howe JR; Lairmore TC; Mishra SK; Dou S; Veile R; Wells SA; Donis-Keller H
Am J Hum Genet; 1992 Dec; 51(6):1430-42. PubMed ID: 1361102
[TBL] [Abstract][Full Text] [Related]
9. Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.
Sobol H; Narod SA; Nakamura Y; Boneu A; Calmettes C; Chadenas D; Charpentier G; Chatal JF; Delepine N; Delisle MJ
N Engl J Med; 1989 Oct; 321(15):996-1001. PubMed ID: 2571086
[TBL] [Abstract][Full Text] [Related]
10. The genetics of multiple endocrine neoplasia (MEN).
Calender A; Schuffenecker I; Lenoir GM
Horm Res; 1992; 38 Suppl 2():16-23. PubMed ID: 1363412
[TBL] [Abstract][Full Text] [Related]
11. A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
Lichter JB; Hackleman SM; Ponder BA; Easton D; Narod SA; Lenoir GM; Gagel RF; Simpson NE; Gardner E; Goodfellow PJ
Henry Ford Hosp Med J; 1992; 40(3-4):205-9. PubMed ID: 1362406
[TBL] [Abstract][Full Text] [Related]
12. Family screening in multiple endocrine neoplasia type 1 (MEN 1).
Larsson C; Nordenskjöld M
Ann Med; 1994 Jun; 26(3):191-8. PubMed ID: 7915525
[TBL] [Abstract][Full Text] [Related]
13. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
14. Prediction of affected MEN2A gene carriers by DNA linkage analysis for early total thyroidectomy: a progress in clinical screening program for children with hereditary cancer syndrome.
Shimotake T; Iwai N; Yanagihara J; Tokiwa K; Tanaka N; Yamamoto M; Takai S
J Pediatr Surg; 1992 Apr; 27(4):444-6. PubMed ID: 1355790
[TBL] [Abstract][Full Text] [Related]
15. Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2A gene using flanking DNA markers.
Howe JR; Lairmore TC; Dou S; Mishra SK; Dilley WG; Donis-Keller H; Wells SA
Surgery; 1992 Aug; 112(2):219-25; discussion 225-6. PubMed ID: 1353639
[TBL] [Abstract][Full Text] [Related]
16. Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.
McMahon R; Mulligan LM; Healey CS; Payne SJ; Ponder M; Ferguson-Smith MA; Barton DE; Ponder BA
Hum Mol Genet; 1994 Apr; 3(4):643-6. PubMed ID: 7915166
[TBL] [Abstract][Full Text] [Related]
17. A new polymorphic marker (D10S97) tightly linked to the multiple endocrine neoplasia type 2A (MEN2A) locus.
Lichter JB; Wu J; Brooks-Wilson AR; Difillipantonio M; Brewster S; Ward DC; Goodfellow PJ; Kidd KK
Hum Genet; 1993 Jan; 90(5):516-20. PubMed ID: 8094065
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia.
Caruso DR; O'Dorisio TM; Mazzaferri EL
Curr Opin Oncol; 1991 Feb; 3(1):103-8. PubMed ID: 1675123
[TBL] [Abstract][Full Text] [Related]
19. The beta subunit locus of the human fibronectin receptor: DNA restriction fragment length polymorphism and linkage mapping studies.
Wu JS; Giuffra LA; Goodfellow PJ; Myers S; Carson NL; Anderson L; Hoyle LS; Simpson NE; Kidd KK
Hum Genet; 1989 Nov; 83(4):383-90. PubMed ID: 2572537
[TBL] [Abstract][Full Text] [Related]
20. [An application of genetic diagnosis in MEN2a].
Kojima K
Nihon Rinsho; 1994 Apr; 52(4):1087-92. PubMed ID: 7910862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
